Humana Inc (HUM) Receives Consensus Recommendation of “Buy” from Analysts

Humana Inc (NYSE:HUM) has been given an average rating of “Buy” by the twenty brokerages that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $339.00.

A number of analysts recently weighed in on the stock. Credit Suisse Group lowered their price target on shares of Humana from $390.00 to $352.00 and set an “outperform” rating for the company in a report on Thursday, February 7th. Citigroup lowered their price target on shares of Humana from $397.00 to $362.00 and set a “buy” rating for the company in a report on Thursday, February 7th. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Friday, February 8th. ValuEngine lowered shares of Humana from a “hold” rating to a “sell” rating in a report on Thursday, April 11th. Finally, Morgan Stanley set a $331.00 price target on shares of Humana and gave the company a “buy” rating in a report on Thursday, May 2nd.

In other news, insider Christopher H. Hunter sold 15,586 shares of Humana stock in a transaction on Monday, February 25th. The shares were sold at an average price of $305.24, for a total transaction of $4,757,470.64. Following the transaction, the insider now directly owns 28,100 shares of the company’s stock, valued at $8,577,244. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Roy A. Beveridge sold 8,278 shares of Humana stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total transaction of $2,542,670.48. Following the transaction, the insider now directly owns 12,409 shares in the company, valued at $3,811,548.44. The disclosure for this sale can be found here. 0.54% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Stephens Inc. AR raised its holdings in shares of Humana by 48.5% during the fourth quarter. Stephens Inc. AR now owns 1,369 shares of the insurance provider’s stock worth $392,000 after acquiring an additional 447 shares during the period. Pacer Advisors Inc. increased its stake in Humana by 6,493.6% in the 1st quarter. Pacer Advisors Inc. now owns 12,396 shares of the insurance provider’s stock valued at $3,298,000 after buying an additional 12,208 shares during the last quarter. Machina Capital S.A.S. acquired a new stake in Humana in the 4th quarter valued at $809,000. Kinneret Advisory LLC acquired a new stake in Humana in the 4th quarter valued at $1,031,000. Finally, Cribstone Capital Management LLC acquired a new stake in Humana in the 1st quarter valued at $230,000. 94.72% of the stock is currently owned by institutional investors.

Shares of Humana stock opened at $247.82 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.65 and a quick ratio of 1.65. The company has a market capitalization of $33.46 billion, a P/E ratio of 17.03, a P/E/G ratio of 1.02 and a beta of 0.88. Humana has a fifty-two week low of $225.65 and a fifty-two week high of $355.88.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, May 1st. The insurance provider reported $4.48 earnings per share for the quarter, beating analysts’ consensus estimates of $4.30 by $0.18. The business had revenue of $16.11 billion during the quarter, compared to analyst estimates of $15.67 billion. Humana had a net margin of 2.99% and a return on equity of 20.77%. Humana’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter last year, the business posted $3.36 earnings per share. Equities analysts predict that Humana will post 17.57 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.55 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $2.20 dividend on an annualized basis and a yield of 0.89%. Humana’s payout ratio is presently 15.12%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More: What is Forex?

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.